Circulating ghrelin in patients with chronic obstructive pulmonary disease

Area of Science:

• Pulmonary Medicine
• Endocrinology
• Metabolic Research

Background:

• Unexplained weight loss is a frequent complication in patients diagnosed with chronic obstructive pulmonary disease (COPD).
• Ghrelin, a hormone crucial for regulating energy balance, has a significant role in maintaining homeostasis.
• Investigating ghrelin levels in COPD is essential to understand the mechanisms behind weight loss.

Purpose of the Study:

• To determine plasma ghrelin levels in patients suffering from chronic obstructive pulmonary disease (COPD).
• To explore the relationship between ghrelin, body composition, and inflammatory markers in COPD.

Main Methods:

• Plasma ghrelin, leptin, tumor necrosis factor-alpha, and C-reactive protein levels were quantified in 29 COPD patients and 17 healthy controls.
• Body composition was assessed using bioelectrical impedance analysis.
• Statistical analyses were performed to compare groups and identify correlations.

Main Results:

• COPD patients exhibited lower body mass index and body fat percentage compared to healthy controls.
• Significantly lower plasma concentrations of ghrelin and leptin were observed in COPD patients.
• Elevated levels of tumor necrosis factor-alpha and C-reactive protein were found in COPD patients, with ghrelin negatively correlating with these inflammatory markers.

Conclusions:

• Plasma ghrelin levels are decreased in individuals with COPD, distinguishing it from other diseases associated with weight loss.
• Reduced ghrelin, coupled with inflammatory processes, likely contributes to altered metabolic status in COPD.
• These findings highlight ghrelin's potential role in the pathophysiology of weight loss in COPD.